Advances in FDA's Safety Program for Marketed Drugs FDA Continues to Lead in Precision Medicine
Advances in FDA's Safety Program for Marketed Drugs FDA Continues to Lead in Precision Medicine出 版 物：《Journal of Chinese Pharmaceutical Sciences》 (中国药学（英文版）)
年 卷 期：2015年第24卷第4期
页 面：268-271页
核心收录：
学科分类：1007[医学-药学(可授医学、理学学位)] 1006[医学-中西医结合] 100706[医学-药理学] 100602[医学-中西医结合临床] 10[医学]
主 题：FDA 安全计划 药品 医学 上市 药物治疗 铅 个性化
摘 要：Everyone knows that different people don’t respond the same way to medications,and that one size does not fit all. FDA has been pushing for targeted drug therapies,sometimes called personalized medicines or precision medicines, for a long *** therapies make use of blood tests,images of the body,or other technologies to measure
维普期刊数据库
同方期刊数据库